High-Dose-RATE Brachytherapy As Monotherapy for Low and Intermediate Risk Prostate Cancer: ACUTE Toxicity of a Randomized Phase II Trial

Autor: Jolicoeur, M., Derashodian, T., Nguyen-Huynh, T.V., de Castro Hellmann, E., Mondat, M., Nachabe, M., Antebi, E., Wakil, G., Héliou, R.
Zdroj: In International Journal of Radiation Oncology, Biology, Physics 1 September 2019 105(1) Supplement:E284-E284
Databáze: ScienceDirect